Recompensation in Alcohol Related Hepatitis

Recruiting N/A Interventional Study
Alcoholic Hepatitis (AH)
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
160 (estimated)
Sponsor
Nina Kimer · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Genetic activity and metabolic changes may be part of the pathogenesis in alcohol related hepatitis. We do not know exactly how alcohol cessation affects liver functions and metabolism. The aim of this study is to assess the impact of alcohol cessation in patients with alcohol related hepatitis and gain knowledge of the metabolic and genetic functions of the liver during remission and recompensat…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Clinical suspicion of AH, supported by biochemistry (bilirubin 50 mmol/l or higher) and ultrasound or other imaging techniques. * Informed written consent. Exclusion Criteria: * People where the diagnosis of AH is questioned with reasonable doubt. * Withdrawal of informed co…
Contacts

Nina Kimer, MD, PhD

+4525140961

nina.kimer@regionh.dk

CONTACT

Niels P Klausen, MD

+4538621968

niels.peter.riedel.klausen@regionh.dk

CONTACT